RecruitingNCT06392568

Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units

Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units: A Prospective Multicenter National Observational Study (NOSOREA-3)


Sponsor

Abderrahmane Mami Hospital

Enrollment

500 participants

Start Date

Apr 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Investigate the epidemiology, risk factors and impact on clinical practice of healthcare-associated infections with emergent highly drug-resistant (eHDR) pathogens, particularly carbapenem resistant enterobacteriaceae and glycopeptides-resistant enterococcus.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Adult ICU patients admitted during the study period

Exclusion Criteria1

  • none

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERepidemiological records

Healthcare associated infections due to emergent highly resistant bacteria, sites, risk factors, treatment and outcome


Locations(1)

Abderrahmen Mami

Ariana, Tunis Governorate, Tunisia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06392568


Related Trials